Literature DB >> 28676409

Enterococci in orthopaedic infections: Who is at risk getting infected?

Ilker Uçkay1, Daniela Pires2, Americo Agostinho2, Nastassia Guanziroli3, Mehmet Öztürk3, Placido Bartolone3, Philippe Tscholl3, Michael Betz3, Didier Pittet4.   

Abstract

Some orthopaedic patients might be at risk for enterococcal infections and might benefit from adapted perioperative prophylaxis.
METHODS: We performed a single-center cohort of adult patients with orthopaedic infections.
RESULTS: Among 2740 infection episodes, 665 surgeries (24%) involved osteosynthesis material, including total joint arthroplasties. The recommended perioperative prophylaxis was cefuroxime (or vancomycin in case of documented MRSA body carriage). Patients had received antibiotic therapy before surgery in 1167 episodes (43%); among them with potential anti-enterococcal activity (penicillins, glycopeptides, imipenem, linezolid, daptomycin, aminoglycosids, tetracyclins) in 725 (62%) cases. Overall, enterococci were identified in intraoperative samples of 100 different infections (3.6%) (Enterococcus faecalis, 95; Enterococcus faecium, 2; and other enterococci, 3). However, only 15/100 (15%) enterococcal infections were monomicrobial and 19 were nosocomial (19/2740; 0.7%), of which 15 had previous cephalosporin perioperative prophylaxis without other antibiotic exposure. This association to prior cephalosporin use was significant (Pearson-χ2-test; 148/2640 vs. 15/100, p < 0.01). By multivariate analysis, the presence of diabetic foot infection (odds ratio 1.9, 95% confidence interval 1.2-2.9), and polymicrobial infection (OR 6.0, 95%CI 3.9-9.4) were the main predictors of enterococcal infection, while sex, age, and type of material were not.
CONCLUSIONS: Community-acquired or nosocomial enterococcal infections in orthopaedic surgery are mostly polymicrobial, rare and very seldom attributed to a nosocomial origin. Thus, even if they are formally associated with prior cephalosporin use, we do not see a rational for changing our antibiotic prophylaxis.
Copyright © 2017 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibiotic use; Enterococci; Epidemiology; Orthopaedic infections; Polymicrobial

Mesh:

Substances:

Year:  2017        PMID: 28676409     DOI: 10.1016/j.jinf.2017.06.008

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  8 in total

Review 1.  Targeting Stem Cells in Chronic Inflammatory Diseases.

Authors:  Mari van de Vyver; Carine Smith; Yigael S L Powrie
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Stopping antibiotics after surgical amputation in diabetic foot and ankle infections-A daily practice cohort.

Authors:  Anne Rossel; Dan Lebowitz; Karim Gariani; Mohamed Abbas; Benjamin Kressmann; Mathieu Assal; Philippe Tscholl; Dimitrios Stafylakis; Ilker Uçkay
Journal:  Endocrinol Diabetes Metab       Date:  2019-02-06

3.  Epidemiology and risk factors of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci infections in Zhejiang China from 2015 to 2017.

Authors:  Lin Huang; Rong Zhang; Yanyan Hu; Hongwei Zhou; Junmin Cao; Huoyang Lv; Shi Chen; Shibiao Ding; Gongxiang Chen
Journal:  Antimicrob Resist Infect Control       Date:  2019-05-30       Impact factor: 4.887

4.  Changing perioperative prophylaxis during antibiotic therapy and iterative debridement for orthopedic infections?

Authors:  Lydia Wuarin; Mohamed Abbas; Stephan Harbarth; Felix Waibel; Dominique Holy; Jan Burkhard; Ilker Uçkay
Journal:  PLoS One       Date:  2019-12-18       Impact factor: 3.240

5.  A Novel Biofilm Model System to Visualise Conjugal Transfer of Vancomycin Resistance by Environmental Enterococci.

Authors:  Michael Conwell; James S G Dooley; Patrick J Naughton
Journal:  Microorganisms       Date:  2021-04-09

6.  How good are clinicians in predicting the presence of Pseudomonas spp. in diabetic foot infections? A prospective clinical evaluation.

Authors:  Ilker Uçkay; Dominique Holy; Madlaina Schöni; Felix W A Waibel; Tudor Trache; Jan Burkhard; Thomas Böni; Benjamin A Lipsky; Martin C Berli
Journal:  Endocrinol Diabetes Metab       Date:  2021-02-09

Review 7.  Enterococcal biofilm-A nidus for antibiotic resistance transfer?

Authors:  Michael Conwell; James S G Dooley; Patrick J Naughton
Journal:  J Appl Microbiol       Date:  2022-01-26       Impact factor: 4.059

8.  Should antibiotic prophylaxis before orthopedic implant surgery depend on the duration of pre-surgical hospital stay?

Authors:  Marie Davat; Lydia Wuarin; Dimitrios Stafylakis; Mohamed Abbas; Stephan Harbarth; Didier Hannouche; Ilker Uçkay
Journal:  Antimicrob Resist Infect Control       Date:  2018-11-08       Impact factor: 4.887

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.